skip to Main Content

3Flow Opens Showcase Test Lab, Modernizes Training Center

August 11, 2022

3Flow, Inc. proudly announces the grand opening of two significant facility improvements at their corporate headquarters in Raleigh-Durham (Cary), North Carolina. 3Flow’s “Showcase Test Lab” will serve as an information hub for laboratory professionals to evaluate and optimize performance of building systems based in intelligent design and integration of smart tools and technologies.

Read more

UCLA: Lab Ventilation Risk Assessment Process

May 23, 2022

The Laboratory Ventilation Risk Assessment (LVRA) is a key component for the Smart Buildings and Labs Program, led by Facilities Management, to safely reduce energy in state-funded buildings and assist with achieving UCOP energy initiatives such as carbon neutrality by 2025 and 2% reduction of energy use intensity on an annual basis.

Read more

The Pandemic Has Suddenly Shined Light On Long-Neglected Indoor Air Concerns

August 16, 2021

For more than 25 years, Tom Smith has run 3Flow, a company whose sole mission is to make sure people don’t get sick from airborne hazards in their workplaces.

Read more

Cary company working to make offices safer from virus for workers

February 25, 2021

A Cary company is running experiments to see how airflow in a building, specifically in a workplace, can impact how COVID-19 germs are spread.

Read more

Webinars

COVID-19 Aerosols: How Airflow Affects Transmission – Session 1

January 19, 2021
In session 1 the presenters discuss how aerosolized pathogens are generated and transmitted indoors; as well as, the links between exposure, dose and infection.

COVID-19 Aerosols: How to Optimize Ventilation – Session 2

January 21, 2021
In session 2 the presenters discuss how ventilation systems operate to increase or decrease risk; the importance of airflow patterns and ventilation effectiveness; and a process to investigate and implement prudent safety measures.

COVID-19 Aerosols: Answers to Your Questions – Session 3

January 26, 2021
Previously recorded Q&A session from the COVID-19 aerosols webinar series.

Back To Top